- Report
- October 2024
- 189 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- September 2024
- 79 Pages
Global
From €3336EUR$3,495USD£2,795GBP
- Report
- May 2024
- 128 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- January 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- November 2023
- 178 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- April 2023
- 105 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- July 2023
- 184 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- October 2022
- 207 Pages
Global
From €3407EUR$3,570USD£2,855GBP
Dysmenorrhea Drug is a type of medication used to treat the pain associated with menstrual cramps. It is a common condition that affects many women of reproductive age. Dysmenorrhea Drug is a part of the Sexual and Reproductive Health Drugs market, which includes medications used to treat a variety of conditions related to sexual and reproductive health. These drugs are used to treat conditions such as infertility, endometriosis, and menopause. They can also be used to prevent pregnancy and to treat sexually transmitted infections.
The Dysmenorrhea Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Bayer AG, Pfizer Inc., Merck & Co., Inc., and GlaxoSmithKline plc. Other companies in the market include Allergan plc, Teva Pharmaceutical Industries Ltd., and Mylan N.V. Show Less Read more
